Načítá se...
A review of rabeprazole in the treatment of acid-related diseases
Rabeprazole is a proton pump inhibitor. Pharmacodynamic data show rabeprazole can achieve optimal acid suppression since the first administration and can maintain this advantage in the following days of therapy. Moreover, rabeprazole has the highest pKa (~ 5.0, the pH at which a drug becomes 50% pro...
Uloženo v:
Hlavní autoři: | , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Dove Medical Press
2007
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2386363/ https://ncbi.nlm.nih.gov/pubmed/18488081 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|